• Home
  • News
  • Special Focus
  • Politics & Policy
  • Viewpoint & Comments
Tuesday, January 27, 2026
Mediatracnet
Advertisement
  • Home
  • News
  • Special Focus
  • Politics & Policy
  • Viewpoint & Comments
No Result
View All Result
  • Home
  • News
  • Special Focus
  • Politics & Policy
  • Viewpoint & Comments
No Result
View All Result
Mediatracnet
No Result
View All Result
Home News

Nigeria, others to receive 16m free doses of COVID-19 vaccines, says UK govt

Bassey Udo by Bassey Udo
February 10, 2021
in News
0
Nigeria, others to receive 16m free doses of COVID-19 vaccines, says UK govt

The Global Vaccine Alliance (GAVI) announced on Tuesday that Nigeria would be one of the first set of countries to receive about 16 million free doses of COVID-19 vaccines as part of the COVAX Global Vaccines Facility of the UK Government.
The British High Commission Office in Nigeria said the free doses of vaccines would be received in the first half of this year.
It said that GAVI had shared the first forecasts of countries that would receive COVID-19 vaccines through COVAX’s Advance Market Commitment (AMC).
The Commission said COVAX has allocated over 330 million doses for low and lower middle-income countries, including Nigeria.
“As one of the 92 official development assistance (ODA)-eligible countries participating in the COVAX AMC initiative, Nigeria will benefit from this arrangement and access free vaccines to cover at least 20 percent of its population. The UK is playing a supportive role in ensuring an effective and equitable introduction of COVID-19 vaccines, “the Commission said.
As a global pandemic that needs a global solution, the Commission said the UK government was at the forefront of tackling COVID-19 internationally.
Already the Commission said the UK government has so far pledged up to 1.3 billion pounds from UK aid to end the coronavirus pandemic as quickly as possible.
The aid, it noted, would be used in championing access to vaccines for all countries, particularly the world’s poorest.
The commission noted that UK was not doing this alone, but as a collective effort with other international partners.
In Nigeria, the Commission said the UK government was supporting an effective roll out of the vaccines through engagement and technical assistance to the Ministry of Health and other relevant stakeholders.
“COVAX is a global initiative to support the development, manufacture, and fair distribution of COVID-19 vaccines for up to one billion people by the end of 2021.
“COVAX is an international alliance co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization, with participation from over 180 countries.
“The UK is one of the largest donors to the COVAX facility and has committed 548 million pounds to the AMC, a scheme that leverages the scale assured by the participation of higher-income economies so that the lower-income countries are able to participate and access COVID-19 vaccines,” the Commission said.
Also, the Commission noted that UK was also one of the largest donors to GAVI, the Vaccine Alliance, which has spent the past two decades expanding and updating cold-chain infrastructure and strengthening routine immunization in lower-income countries.
The UK is a member of the Technical Working Group (TWG) for the roll-out of the National Deployment and Vaccines Plan (NDVP), led by the National Primary Health Care Development Agency (NPHCDA), and member of the Presidential Task Force on COVID-19 since it was established by President Muhammadu Buhari on March 9, 2020.
The British High Commissioner, Catriona Laing, said: “This news on the COVAX global COVID-19 vaccine roll out brings us one step closer to delivering vaccines to millions of Nigerians.
“I am pleased that Nigeria will get millions of these free doses by the end of 2021.
“The UK is playing a global role in promoting an effective roll out, including as one of the largest COVAX donors and through our engagement with the Nigerian-led response,“ Mr Laing said. (NAN)

Tags: COVID-19 vaccineGAVIsNigeria
Previous Post

Akwa Ibom govt. courts U.S, other investors to partner in Ibom Deep Seaport project

Next Post

With every 5th Chinese above 60, China population is aging fast

Bassey Udo

Bassey Udo

Bassey Udo is a Journalist, Communication & Media Practitioner PERSONAL DETAILS DATE OF BIRTH: March 3, 1965 GENDER: Male NATIONALITY: Nigerian GSM: +234 802 313 7335; 07032308000 EMAIL: bassey.udo@gmail.com CONTACT ADDRESS: Plot 743 Coral Park Street, Lugbe CRD, Abuja, FCT 900128 A multiple award winning investigative reporter with specialised interest in Business & Economy, Energy & Power, Oil, Gas, Mining & Extractive Industry, Environment & Climate Change, etc. at various times for some of Nigeria’s elite newspapers and magazines, including Post Express, NewsAfrica magazine, Independent, 234NEXT and Premium Times. A member of the Nigerian Guild of Editors (NGE), Nigeria Union of Journalists (NUJ), Nigerian Institute of Public Relations (NIPR) and Society of International Law & Diplomacy (SILD). He is also a distinguished Alumnus of the U.S. International Visitors Leadership Programme (IVLP) 2017.

Next Post
With every 5th Chinese above 60, China population is aging fast

With every 5th Chinese above 60, China population is aging fast

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Browse by Category

  • Business & Economy
  • Energy Transition & Global Environment
  • Labour & Productivity
  • News
  • Politics
  • Politics & Policy
  • Religion
  • Science & Technology
  • Social Business
  • Special Focus
  • Sport & Entertainment
  • Viewpoint & Comments
  • Visualisations
  • World
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 Mediatracnet - tracking news for community value... Powered by Zilisoft Tech.

No Result
View All Result
  • Home
  • News
  • Special Focus
  • Politics & Policy
  • Viewpoint & Comments

© 2023 Mediatracnet - tracking news for community value... Powered by Zilisoft Tech.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.